Skip to main content
. 2024 Jul 12;15:1382120. doi: 10.3389/fphar.2024.1382120

FIGURE 3.

FIGURE 3

Cost-effectiveness Acceptability Curves (A) Cost-effectiveness acceptability curves of PC in comparison with T-DM1 (B) Cost-effectiveness acceptability curves of T-DXd in comparison with T-DM1. Abbreviations: CEAC, cost-effectiveness acceptability curve; T-DM1, T-DMI; T-DXd, trastuzumab deruximab; PC, PC.